Vol 89, No 10 (2018)
Research paper
Published online: 2018-10-31

open access

Page views 1866
Article views/downloads 1276
Get Citation

Connect on Social Media

Connect on Social Media

Hysterectomy in Poland between 2011 and 2016. Changing trends in the surgical approach to hysterectomy

Piotr Lepka12, Marcin Jędryka12, Marcin Misiek3, Rafał Matkowski12
Pubmed: 30393839
Ginekol Pol 2018;89(10):529-535.

Abstract

Objectives: In Poland, approximately 35,000 women a year undergo hysterectomy. The surgical approach may vary depending on the indications and experience of the operator and advances in laparoscopic surgical techniques. The aim of the present study was to analyze trends in the use of various types of hysterectomy in Poland between 2011 and 2016. Summary values were given as numbers and percentages. Annual incidence of procedures and identify factors which influence these changes in gynecological practice.
Material and methods: Data on hysterectomy procedures performed between 2011 and 2016 in Poland acquired from the National Health Fund reports were extracted and analyzed. Summary values were given as numbers, percentages and rate ratios (RR). Annual incidence of procedures and identify factors that influence these changes in gynecological practice.
Results: Between 2011 and 2016, 215,744 women were treated by hysterectomy in inpatient settings. The total number of those procedures in analyzed period decreased by 11.5%; the incidence rate dropped by 2.15 per 100,000 women. A significant increase in laparoscopic procedures was observed (RR = 3.85; CI: 3.57–4.16; p < 0.001) along with a decrease in the number of abdominal operations (RR = 0.82; CI: 0.81–0.83; p < 0.001).
Conclusions: Surgical technique advances, introduction of intrauterine systems and hormonal therapy, as well as recommendations of international institutions have brought about changes in the methods and frequency of hysterectomy. The laparoscopic approach has been gaining popularity since it is beneficial both for patients and public health system. However, the percentage of advanced minimally invasive hysterectomies is still low in Poland in comparison to other countries.

Article available in PDF format

View PDF Download PDF file

References

  1. Romanek-Piva K, Gałczyński K, Adamiak-Godlewska A, et al. Hysterectomy trends for benign indications over a 15-year period in an academic teaching center in Poland: a retrospective cohort study. Ginekol Pol. 2016; 87(6): 411–416.
  2. Papadopoulos MS, Tolikas AC, Miliaras DE. Hysterectomy-current methods and alternatives for benign indications. Obstet Gynecol Int. 2010; 2010.
  3. Finks JF, Osborne NH, Birkmeyer JD. Trends in hospital volume and operative mortality for high-risk surgery. N Engl J Med. 2011; 364(22): 2128–2137.
  4. Streuli I, de Ziegler D, Santulli P, et al. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013; 14(3): 291–305.
  5. Sambrook AM, Bain C, Parkin DE, et al. A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium: follow up at a minimum of 10 years. BJOG. 2009; 116(8): 1033–1037.
  6. Gupta J, Kai J, Middleton L, et al. ECLIPSE Trial Collaborative Group. Levonorgestrel intrauterine system versus medical therapy for menorrhagia. N Engl J Med. 2013; 368(2): 128–137.
  7. Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer. Lancet Oncol. 2011; 12(2): 192–200.
  8. Driessen SRC, Baden NLM, van Zwet EW, et al. Trends in the implementation of advanced minimally invasive gynecologic surgical procedures in the Netherlands. J Minim Invasive Gynecol. 2015; 22(4): 642–647.
  9. Mäkinen J, Brummer T, Jalkanen J, et al. Ten years of progress--improved hysterectomy outcomes in Finland 1996-2006: a longitudinal observation study. BMJ Open. 2013; 3(10): e003169.
  10. Gupta J, Sinha A, Lumsden MA, et al. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews. 2014; 12.
  11. Wright JD, Herzog TJ, Tsui J, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol. 2013; 122(2 Pt 1): 233–241.
  12. Balcı O. Comparison of total laparoscopic hysterectomy and abdominal hysterectomy. Turk J Obstet Gynecol. 2014; 11(4): 224–227.
  13. Kürek Eken M, İlhan G, Temizkan O, et al. The impact of abdominal and laparoscopic hysterectomies on women's sexuality and psychological condition. Turk J Obstet Gynecol. 2016; 13(4): 196–202.
  14. Mourits MJE, Bijen CB, Arts HJ, et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol. 2010; 11(8): 763–771.
  15. Deffieux X, Rochambeau Bde, Chene G, et al. Hysterectomy for benign disease: clinical practice guidelines from the French College of Obstetrics and Gynecology. Eur J Obstet Gynecol Reprod Biol. 2016; 202: 83–91.
  16. Schöller D, Taran FA, Wallwiener M, et al. Laparoscopic Supracervical Hysterectomy and Laparoscopic Total Hysterectomy in Patients with Very Large Uteri: a Retrospective Single-Center Experience at a Major University Hospital. Geburtshilfe Frauenheilkd. 2017; 77(3): 251–256.
  17. Uccella S, Morosi C, Marconi N, et al. Laparoscopic Versus Open Hysterectomy for Benign Disease in Uteri Weighing >1 kg: A Retrospective Analysis on 258 Patients. J Minim Invasive Gynecol. 2018; 25(1): 62–69.
  18. Edler KM, Tamussino K, Fülöp G, et al. Rates and Routes of Hysterectomy for Benign Indications in Austria 2002 - 2014. Geburtshilfe Frauenheilkd. 2017; 77(5): 482–486.
  19. Barron KI, Richard T, Robinson PS, et al. Association of the U.S. Food and Drug Administration Morcellation Warning With Rates of Minimally Invasive Hysterectomy and Myomectomy. Obstet Gynecol. 2015; 126(6): 1174–1180.
  20. Glaser LM, Friedman J, Tsai S, et al. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines. Best Pract Res Clin Obstet Gynaecol. 2018; 46: 99–112.
  21. Multinu F, Casarin J, Hanson KT, et al. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation. JAMA Surg. 2018; 153(6): e180141.
  22. Halaska MJ, Haidopoulos D, Guyon F, et al. ESGO Council. European Society of Gynecological Oncology Statement on Fibroid and Uterine Morcellation. Int J Gynecol Cancer. 2017; 27(1): 189–192.
  23. Leal MA, Piñera A, De Santiago J, et al. Novel Technique for Contained Power Morcellation through Umbilicus with Insufflated Bag. Gynecol Obstet Invest. 2017; 82(2): 205–207.
  24. Rechberger T, Miotła P, Futyma K, et al. Power morcellation for women undergoing laparoscopic supracervical hysterectomy - safety of procedure and clinical experience from 426 cases. Ginekol Pol. 2016; 87(8): 546–551.
  25. Aarts J, Nieboer T, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database of Systematic Reviews. 2015.
  26. ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol. 2009; 114(5): 1156–1158.
  27. Neis KJ, Zubke W, Römer T, et al. Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015). Geburtshilfe Frauenheilkd. 2016; 76(4): 350–364.
  28. Walsh CA, Walsh SR, Tang TY, et al. Total abdominal hysterectomy versus total laparoscopic hysterectomy for benign disease: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2009; 144(1): 3–7.